Eye2gene Limited
Company Profile
live
UnknownEye2gene Limited
11534583•Private Limited With Share Capital
2 Eastbourne Terrace, London, W26LG
Get Full Access
Incorporated
23/08/2018
Company Age
7 years
Directors
5
Employees
—
SIC Code
86101
Risk
not scored
Company Overview
Registration, classification & business activity
Eye2gene Limited (11534583) is a private limited with share capital incorporated on 23/08/2018 (7 years old) and registered in london, W26LG. The company operates under SIC code 86101 - hospital activities.
Eye2gene helps provide a genetic diagnosis for people with progressive sight-loss caused by an inherited retinal dystrophy (ird) faster than ever before.over 300 gene mutations are known to cause ird and a genetic diagnosis is a significant step towards managing, and possibly treating, people's sigh...
Private Limited With Share Capital
SIC: 86101
Unknown
Incorporated 23/08/2018
W26LG
Financial Overview
Total Assets
£1
Liabilities
£0
Net Assets
£1
Cash
£0
Key Metrics
5
Directors
1
Shareholders
Board of Directors
4
Name
Position
director
director
director
director
Filed Documents
27
Document Name
Category
Date
Resolution
Category:Resolution
Date:21-04-2026
Memorandum Articles
Category:Incorporation
Date:21-04-2026
Capital Allotment Shares
Category:Capital
Date:15-04-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:24-03-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:24-03-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:24-03-2026
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:12-03-2026
Resolution
Category:Resolution
Date:27-12-2025
Capital Alter Shares Subdivision
Category:Capital
Date:27-12-2025
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:22-12-2025
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:22-12-2025
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:22-12-2025
Capital Allotment Shares
Category:Capital
Date:19-12-2025
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:08-09-2025
Accounts With Accounts Type Dormant
Category:Accounts
Date:01-05-2025
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:01-09-2024
Accounts With Accounts Type Dormant
Category:Accounts
Date:03-06-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:13-09-2023
Accounts With Accounts Type Dormant
Category:Accounts
Date:18-05-2023
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:02-09-2022
Accounts With Accounts Type Dormant
Category:Accounts
Date:01-05-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:24-08-2021
Accounts With Accounts Type Dormant
Category:Accounts
Date:03-05-2021
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:28-08-2020
Accounts With Accounts Type Dormant
Category:Accounts
Date:07-10-2019
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:25-08-2019
Incorporation Company
Category:Incorporation
Date:23-08-2018
Risk Assessment
not scored
International Score
Future Factor
emerging
Performance Rating
Accounts
Typedormant
Due Date31/05/2026
Filing Date01/05/2025
Latest Accounts31/08/2024
Trading Addresses
2 Eastbourne Terrace, London, W26LGRegistered
Related Companies
3
Contact
eye2gene.com
2 Eastbourne Terrace, London, W26LG